Ery-Ped
NDC 24338-132, Erythromycin Ethylsuccinate, suspension, from Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).
- Product NDC
- 24338-132
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA050207
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24338-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE200 mg/5mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24338-132-13 | 24338013213 | 100 mL in 1 BOTTLE (24338-132-13) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/04775721-ab87-4b66-808c-d67a21032385
Use it
Look up 24338-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24338-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24338-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.